Back

Effect of timely availability of TTR-stabilizing therapy on diagnosis, treatment initiation, and cardiovascular outcomes in transthyretin amyloid cardiomyopathy

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Heart failure phenotypes, diagnostics, and outcomes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Stephan Dobner

Wilhelminen Hospital, Vienna (Austria)

7 More presentations in this session

Presentation thumbnail
The impact of worsening heart failure (WHF) status on subsequent outcomes among patients with HFrEF: History of WHF events is associated with worse subsequent outcomes regardless of extent of GDMT
Doctor L. Bash (Rahway, US) Doctor A. Stevenson (Chatham, US)
Abstract Slides Video
Presentation thumbnail
Prognostic value of NT-proBNP and cardiac troponin levels in ambulatory patients with congestive heart failure - Insight from NHANES.
Doctor Y. Sattar (West Virginia, US)
Abstract Slides Video
Presentation thumbnail
Association between liver stiffness and congestive heart failure; analysis of the NHANES 2017 - 2020
Doctor P. Wattanachayakul (Philadelphia, US)
Abstract Slides
Presentation thumbnail
Impact of cardiac power output, invasively measured by right heart catheterization, on exercise capacity and clinical outcomes in patients with chronic heart failure
Doctor Y. Shimono (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomes
Doctor S. Ratwatte (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure phenotypes, diagnostics, and outcomes

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources